1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Comparison between ticagrelor and clopidogrel in myocardial infarction patients with high bleeding risk
(
- Contribution to journal › Article
- 2021
-
Mark
Low Adherence to Statin Treatment during the First Year after an Acute Myocardial Infarction is associated with Increased Second Year Mortality Risk- An Inverse Probability of Treatment Weighted Study on 54,872 Patients
(
- Contribution to journal › Article
-
Mark
Beta-blocker therapy after myocardial infarction guided by left ventricular ejection fraction : Is 50 the new 40?
(
- Contribution to journal › Debate/Note/Editorial
- 2020
-
Mark
Relationship between degree of heparin anticoagulation and clinical outcome in patients receiving potent P2Y12-inhibitors with no planned glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention in acute myocardial infarction : a VALIDATE-SWEDEHEART substudy
(
- Contribution to journal › Article
- 2019
-
Mark
Clinical use of cangrelor : nationwide experience from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
(
- Contribution to journal › Article
- 2018
-
Mark
Antithrombotic therapy after myocardial infarction in patients with atrial fibrillation undergoing percutaneous coronary intervention
(
- Contribution to journal › Article
- 2017
-
Mark
Diabetic patients with acute coronary syndromes in contemporary European registries : Characteristics and outcomes
(
- Contribution to journal › Article
- 2016
-
Mark
Risk factor changes and incident atrial fibrillation among middle-aged men in the Malmö Preventive Project cohort
(
- Contribution to journal › Article
-
Mark
P2Y12 receptor inhibitors in patients with non-STelevation acute coronary syndrome in the real world : Use, patient selection, and outcomes from contemporary European registries
(
- Contribution to journal › Article
-
Mark
Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registries
(
- Contribution to journal › Article